The prognosis of patients with glioblastoma, the most malignant adult glial brain tumor, remains poor in spite of advances in treatment procedures, including surgical resection, irradiation and chemotherapy. Genetic heterogeneity of glioblastoma warrants extensive studies in order to gain a thorough understanding of the biology of this tumor. While there have been several studies of global transcript profiling of glioma with the identification of gene signatures for diagnosis and disease management, translation into clinics is yet to happen. Serum biomarkers have the potential to revolutionize the process of cancer diagnosis, grading, prognostication and treatment response monitoring. Besides having the advantage that serum can be obtained ...
PurposeGliomas are one of the most aggressive and lethal brain tumors arising from neoplastic transf...
<div><p>Glioblastoma multiform (GBM) remains clinical indication with significant “unmet medical nee...
International audienceUNLABELLED: ABSTRACT: BACKGROUND: Genomics, transcriptomics and proteomics of ...
The prognosis of patients with glioblastoma, the most malignant adult glial brain tumor, remains p...
Glioblastoma multiforme (GBM) or grade IV astrocytoma is the most common and lethal adult malignant ...
Glioblastoma multiforme is the most aggressive malignant tumor of the central nervous system. Due to...
Gliomas in the form of astrocytomas, anaplastic astrocytomas and glioblastomas are the most common b...
Abstract Background Genomics, transcriptomics and proteomics of glioblastoma multiforme (GBM) have r...
Background: Genomics, transcriptomics and proteomics of glioblastoma multiforme (GBM) have recently ...
Background. Glioblastoma multiforme (GBM) is a brain tumour with a very high patient mortality rate,...
Molecular biomarkers in blood are needed to aid the early diagnosis and clinical assessment of gliob...
<div><p>Molecular biomarkers in blood are needed to aid the early diagnosis and clinical assessment ...
The 2016 WHO Classification of Tumors of the Central Nervous System separates IDH-mutant gliomas int...
Glioblastoma (GB) is a primary malignancy of the central nervous system that is classified by the WH...
The WHO classification of brain tumors is based on histological features and the aggressiveness of t...
PurposeGliomas are one of the most aggressive and lethal brain tumors arising from neoplastic transf...
<div><p>Glioblastoma multiform (GBM) remains clinical indication with significant “unmet medical nee...
International audienceUNLABELLED: ABSTRACT: BACKGROUND: Genomics, transcriptomics and proteomics of ...
The prognosis of patients with glioblastoma, the most malignant adult glial brain tumor, remains p...
Glioblastoma multiforme (GBM) or grade IV astrocytoma is the most common and lethal adult malignant ...
Glioblastoma multiforme is the most aggressive malignant tumor of the central nervous system. Due to...
Gliomas in the form of astrocytomas, anaplastic astrocytomas and glioblastomas are the most common b...
Abstract Background Genomics, transcriptomics and proteomics of glioblastoma multiforme (GBM) have r...
Background: Genomics, transcriptomics and proteomics of glioblastoma multiforme (GBM) have recently ...
Background. Glioblastoma multiforme (GBM) is a brain tumour with a very high patient mortality rate,...
Molecular biomarkers in blood are needed to aid the early diagnosis and clinical assessment of gliob...
<div><p>Molecular biomarkers in blood are needed to aid the early diagnosis and clinical assessment ...
The 2016 WHO Classification of Tumors of the Central Nervous System separates IDH-mutant gliomas int...
Glioblastoma (GB) is a primary malignancy of the central nervous system that is classified by the WH...
The WHO classification of brain tumors is based on histological features and the aggressiveness of t...
PurposeGliomas are one of the most aggressive and lethal brain tumors arising from neoplastic transf...
<div><p>Glioblastoma multiform (GBM) remains clinical indication with significant “unmet medical nee...
International audienceUNLABELLED: ABSTRACT: BACKGROUND: Genomics, transcriptomics and proteomics of ...